The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate an...
Main Authors: | Jiaochan Han, Xing Li, Xiaoqing Luo, Juan He, Xuechan Huang, Qingyou Zhou, Yanping Han, Hongyu Jie, Jian Zhuang, Yehao Li, Fangyuan Yang, Zeqing Zhai, Shufan Wu, Yi He, Bin Yang, Erwei Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220310404 |
Similar Items
-
The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
by: David M. Stevens, et al.
Published: (2021-12-01) -
Caution of retinal toxicity using chloroquine and hydroxychloroquine in the treatment of COVID-19
by: Li-Yuan Wang, et al.
Published: (2020-07-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01) -
Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)